{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:58:34Z","timestamp":1785445114617,"version":"3.56.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Vulvovaginal candidiasis (VVC) is a common fungal infection in women, primarily caused by\n                      <jats:italic>Candida<\/jats:italic>\n                      species. Biofilm formation is a key virulence factor contributing to pathogenicity and antifungal resistance. This study aimed to identify\n                      <jats:italic>Candida<\/jats:italic>\n                      species, evaluate antifungal susceptibility, quantify biofilm formation, and detect virulence gene markers (\n                      <jats:italic>ALS1<\/jats:italic>\n                      and\n                      <jats:italic>HWP1<\/jats:italic>\n                      ) in vaginal isolates from women with VVC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was conducted from December 2021 to June 2024 among 400 women attending obstetrics and gynecology clinics in Sana\u2019a City. Vaginal swabs were collected and cultured in a microbiology laboratory. Antifungal susceptibility of isolates to nystatin, voriconazole, fluconazole, ketoconazole, clotrimazole, miconazole, itraconazole, and amphotericin B was assessed using the disk diffusion method. Biofilm formation was measured using the microtiter plate assay. The presence of\n                      <jats:italic>ALS1<\/jats:italic>\n                      and\n                      <jats:italic>HWP1<\/jats:italic>\n                      genes was determined by PCR. Data were analyzed using SPSS version 20, and associations were evaluated with the Chi-square test;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>C. albicans<\/jats:italic>\n                      was identified in 367 (91.8%) isolates, while non-\n                      <jats:italic>albicans<\/jats:italic>\n                      species accounted for 33 (8.2%). Of the 367\n                      <jats:italic>C. albicans<\/jats:italic>\n                      isolates, 174 (47.4%) formed biofilms: 32 (8%) strong, 72 (18%) moderate, and 70 (17.5%) weak. Biofilm- forming isolates were associated with higher antifungal resistance, with amphotericin B (113; 64.9%) and itraconazole (108; 62.1%) showing the highest resistance, and nystatin the lowest (23; 13.2%). The\n                      <jats:italic>ALS1<\/jats:italic>\n                      gene was detected in all biofilm- forming\n                      <jats:italic>C. albicans<\/jats:italic>\n                      isolates (174; 100%), while\n                      <jats:italic>HWP1<\/jats:italic>\n                      was present in 82 (47.1%). Non-biofilm-forming isolates demonstrated lower resistance rates across all drugs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>VVC remains highly prevalent in Sana\u2019a, Yemen, with C. albicans as the dominant pathogen. These findings suggest a potential association between biofilm formation and increased antifungal resistance also the presence of key virulence genes\u2014particularly ALS1 and HWP1. However, due to the study\u2019s cross-sectional design, a definitive causal relationship cannot be inferred.<\/jats:p>\n                    <jats:p>\n                      This study emphasizes the importance of integrating phenotypic and molecular characterization into routine diagnostics and surveillance to improve the management of resistant Candida infections. Continuous monitoring of species distribution is also warranted to detect emerging non-\n                      <jats:italic>albicans<\/jats:italic>\n                      species.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-026-05241-y","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:02:30Z","timestamp":1781607750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vulvovaginal candidiasis among Yemeni women: prevalence of Candida species, biofilm formation rates, antifungal susceptibility patterns, and biofilm-associated genes ALS1 and HWP1"],"prefix":"10.1186","volume":"26","author":[{"given":"Abeer Abdulmahamood","family":"Nasher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowa Mohammed","family":"Assayaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Abdulwahab","family":"Al-Shamahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Yahia","family":"Al-Jaufy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa Mohammed","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Al-Raoof Mohammad","family":"Al-Shawkany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad Hassan","family":"Al-Shamahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"5241_CR1","unstructured":"Women\u2019s health.gov report. Vaginal yeast infections fact sheet. Women\u2019s health.gov. December 23, 2014. Archived from the original on 4 March 2015. Retrieved 5 March 2024."},{"key":"5241_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Vulvovaginal candidiasis \u2013 STI treatment guidelines. Atlanta (GA): CDC; 2021 [cited 2025 Jun 6]. Available from: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/candidiasis.htm."},{"key":"5241_CR3","doi-asserted-by":"crossref","unstructured":"Rathod SD, Klausner JD, Krupp K, Reingold AL, Madhivanan P. Epidemiologic features of vulvovaginal candidiasis among reproductive-age women in India, Infectious Diseases in Obstetrics and Gynecology. 2012;2012:859071.","DOI":"10.1155\/2012\/859071"},{"issue":"2","key":"5241_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejogrb.2012.12.001","volume":"167","author":"MI Rosa","year":"2013","unstructured":"Rosa MI, Silva BR, Pires PS, et al. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2013;167(2):132\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"5241_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s11046-018-0261-x","volume":"183","author":"S Hilmio\u011flu-Polat","year":"2018","unstructured":"Hilmio\u011flu-Polat S, Sharifynia S, \u00d6z Y, et al. Genetic diversity and antifungal susceptibility of Candida parapsilosis sensu stricto isolated from bloodstream infections in Turkish patients. Mycopathologia. 2018;183(4):701\u20138.","journal-title":"Mycopathologia"},{"key":"5241_CR6","doi-asserted-by":"crossref","unstructured":"Rolo J, Faria-Gon\u00e7alves P, Barata T et al. Species distribution and antifungal susceptibility profiles of isolates from women with nonrecurrent and recurrent vulvovaginal candidiasis. Microb Drug Resist. 2021.","DOI":"10.1089\/mdr.2020.0139"},{"issue":"2","key":"5241_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/viru.22913","volume":"4","author":"FL Mayer","year":"2013","unstructured":"Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119\u201328.","journal-title":"Virulence"},{"key":"5241_CR8","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Cerdeira C, Gregorio MC, Molares-Vila A, et al., \u201cBiofilms and vulvovaginal candidiasis,\u201d Colloids and Surfaces. B, Biointerfaces. 2019;174:110\u2013125.","DOI":"10.1016\/j.colsurfb.2018.11.011"},{"issue":"4","key":"5241_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0966-842X(01)01984-9","volume":"9","author":"LL Hoyer","year":"2001","unstructured":"Hoyer LL. The _ALS_ gene family of _Candida albicans_. Trends Microbiol. 2001;9(4):176\u201380.","journal-title":"Trends Microbiol"},{"key":"5241_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fmicb.2016.00280","volume":"7","author":"LL Hoyer","year":"2016","unstructured":"Hoyer LL, Cota E. Candida albicans agglutinin-like sequence (Als) family vignettes: a review of Als protein structure and function. Front Microbiol. 2016;7:280.","journal-title":"Front Microbiol"},{"key":"5241_CR11","doi-asserted-by":"crossref","unstructured":"Phan QT, Myers CL, Fu Y et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells, PLoS Biology. 2007;5(3):e64.","DOI":"10.1371\/journal.pbio.0050064"},{"issue":"1","key":"5241_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11046-008-9148-6","volume":"167","author":"H Nailis","year":"2009","unstructured":"Nailis H, Vandenbroucke R, Tilleman K, Deforce D, Nelis H, Coenye T. Monitoring ALS1 and ALS3 gene expression during in vitro Candida albicans biofilm formation under continuous flow conditions. Mycopathologia. 2009;167(1):9\u201317.","journal-title":"Mycopathologia"},{"issue":"10","key":"5241_CR13","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1128\/EC.00194-06","volume":"5","author":"CJ Nobile","year":"2006","unstructured":"Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell. 2006;5(10):1604\u201310.","journal-title":"Eukaryot Cell"},{"issue":"39","key":"5241_CR14","doi-asserted-by":"publisher","first-page":"40737","DOI":"10.1074\/jbc.M406005200","volume":"279","author":"JS Staab","year":"2004","unstructured":"Staab JS, Bahn Y-S, Tai C-H, Cook PF, Sundstrom P. Expression of transglutaminase substrate activity on _Candida albicans_ germ tubes through a coiled, disulfide-bonded N-terminal domain of Hwp1 requires C-terminal glycosylphosphatidylinositol modification. J Biol Chem. 2004;279(39):40737\u201347.","journal-title":"J Biol Chem"},{"issue":"362","key":"5241_CR15","first-page":"2105","volume":"33","author":"M Javaheri","year":"2016","unstructured":"Javaheri M, Mohammadi F, Chadeganipour M, Nekoian S. Dehghan,Identification of Candida species in oral cavity of smokers and nonsmokers. J Isfahan Med School. 2016;33(362):2105\u201310.","journal-title":"J Isfahan Med School"},{"issue":"1","key":"5241_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.mimet.2009.07.016","volume":"79","author":"O Romeo","year":"2009","unstructured":"Romeo O, Scordino F, Pernice I, Passo CL, Criseo G. A multiplex PCR protocol for rapid identification of _Candida glabrata_ and its phylogenetically related species _Candida nivariensis_ and _Candida bracarensis_. J Microbiol Methods. 2009;79(1):117\u201320.","journal-title":"J Microbiol Methods"},{"issue":"2","key":"5241_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26717\/BJSTR.2018.11.002072","volume":"11","author":"OAE Al-Dossary","year":"2018","unstructured":"Al-Dossary OAE, Hassan A, Al-Shamahy. Oral Candida albicans colonization in dental prosthesis patients and individuals with natural teeth, Sana\u2019a city. Yemen Biomed J Sci Tech Res. 2018;11(2):1\u20137. https:\/\/doi.org\/10.26717\/BJSTR.2018.11.002072.","journal-title":"Yemen Biomed J Sci Tech Res"},{"issue":"5","key":"5241_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.22270\/ujpr.v2i","volume":"2","author":"AM Al-Kebsi","year":"2017","unstructured":"Al-Kebsi AM, Othman MO, AlShamahy HA, et al. Oral C. albicans colonization and non-Candida albicans candida colonization among university students. Yemen Univers J Pharm Res. 2017;2(5):5\u201311. https:\/\/doi.org\/10.22270\/ujpr.v2i.","journal-title":"Yemen Univers J Pharm Res"},{"issue":"4","key":"5241_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.22270\/ujpr.v3i4.176","volume":"3","author":"KA Al-Haddad","year":"2018","unstructured":"Al-Haddad KA, Al-dossary OAE, Al-Shamahy HA. Prevalence and associated factors of oral non-Candida albicans Candida carriage in denture wearers in Sana\u2019a city-Yemen. Univers J Pharm Res. 2018;3(4):7\u201311. https:\/\/doi.org\/10.22270\/ujpr.v3i4.176.","journal-title":"Univers J Pharm Res"},{"issue":"3","key":"5241_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22270\/ujpr.v6i3.613","volume":"6","author":"SMM Al-Hatami","year":"2021","unstructured":"Al-Hatami SMM, Al-Moyed KAA, Al-Shamahy HA, AlHaddad MA, Al-Ankoshy AAM. Vulvovaginal candidiasis: Prevalence, species distribution and risk factors among non-pregnant women, in Sana\u2019a, Yemen. Univers J Pharm Res. 2021;6(3):1\u20138. https:\/\/doi.org\/10.22270\/ujpr.v6i3.613.","journal-title":"Univers J Pharm Res"},{"issue":"3","key":"5241_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22270\/ujpr.v5i3.407","volume":"5","author":"AA Al-Rukeimi","year":"2020","unstructured":"Al-Rukeimi AA, Al-Hatami SMM, AL-Danany DA, et al. Prevalence and risk factors associated with vulvovaginal candidiasis during pregnancy in Sana\u2019a, Yemen. Univers J Pharm Res. 2020;5(3):1\u20138. https:\/\/doi.org\/10.22270\/ujpr.v5i3.407.","journal-title":"Univers J Pharm Res"},{"key":"5241_CR22","doi-asserted-by":"crossref","unstructured":"Marot-Leblond A, Nail-Billaud S, Pilon F, Beucher B, Poulain D, Robert R. Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test. J Clin Microbiol.\u00a02009;47(12):3821\u20135.","DOI":"10.1128\/JCM.01168-09"},{"key":"5241_CR23","unstructured":"Kalia N, Singh J, Sharma S, Kamboj SS, Arora H, Kaur M. Prevalence of vulvovaginal infections and species specific distribution of vulvovaginal candidiasis in married women of north India. Int J Curr Microbiol App Sci. 2015;4(8):253\u201366."},{"key":"5241_CR24","doi-asserted-by":"crossref","unstructured":"Knoll MA, Steixner S, Lass-Fl\u00f6rl C. How to use direct microscopy for diagnosing fungal infections. Clin Microbiol Infect. 2023;29(8):1031\u20138.","DOI":"10.1016\/j.cmi.2023.05.012"},{"key":"5241_CR25","doi-asserted-by":"crossref","unstructured":"Abdul-Aziz M, Mahdy MA, Abdul-Ghani R, Alhilali NA, Al-Mujahed LK, Alabsi SA, Al-Shawish FA, Alsarari NJ, Bamashmos W, Abdulwali SJ, Karawani A. M. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana\u2019a city, Yemen. BMC infectious diseases. 2019;19(1):879.","DOI":"10.1186\/s12879-019-4549-3"},{"issue":"1","key":"5241_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1128\/iai.37.1.318-326.1982","volume":"37","author":"GD Christensen","year":"1982","unstructured":"Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982;37(1):318\u201326.","journal-title":"Infect Immun"},{"key":"5241_CR27","doi-asserted-by":"crossref","unstructured":"Stepanovi\u0107 S, Vukovi\u0107 D, Hola V, Bonaventura GD, Djuki\u0107 S, \u0106irkovi\u0107 I, Ruzicka F. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. Apmis. 2007;115(8):891\u20139.","DOI":"10.1111\/j.1600-0463.2007.apm_630.x"},{"issue":"1","key":"5241_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12903-023-02970-8","volume":"23","author":"F Mohammadi","year":"2023","unstructured":"Mohammadi F, Charkhchian M, Mirzadeh M. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients. BMC Oral Health. 2023;23(1):261.","journal-title":"BMC Oral Health"},{"key":"5241_CR29","doi-asserted-by":"crossref","unstructured":"Gerges MA, Fahmy YA, Hosny T, Gandor NH, Mohammed SY, Mohamed TM, Abdelmoteleb NE, Esmaeel NE. Biofilm formation and aspartyl proteinase activity and their association with azole resistance among Candida albicans causing vulvovaginal candidiasis, Egypt. Infection and Drug Resistance. 2023:5283\u201393.","DOI":"10.2147\/IDR.S420580"},{"key":"5241_CR30","volume-title":"Methods for antifungal disk diffusion susceptibility testing of yeasts; approved guideline\u20142nd ed. CLSI document M44-A2","author":"Clinical and Laboratory Standards Institute","year":"2009","unstructured":"Clinical and Laboratory Standards Institute. Methods for antifungal disk diffusion susceptibility testing of yeasts; approved guideline\u20142nd ed. CLSI document M44-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2009."},{"key":"5241_CR31","unstructured":"HiMedia Laboratories Pvt Ltd. Antifungal susceptibility disks: interpretative criteria and quality control ranges. Mumbai: HiMedia Laboratories; 2024."},{"issue":"4","key":"5241_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/0974-777X.91059","volume":"3","author":"K Zomorodian","year":"2011","unstructured":"Zomorodian K, Rahimi MJ, Pakshir K, Motamedi M, Ghiasi MR, Rezashah H. Determination of antifungal susceptibility patterns among the clinical isolates of Candida species. J global Infect Dis. 2011;3(4):357\u201360.","journal-title":"J global Infect Dis"},{"issue":"4","key":"5241_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1128\/AAC.14.4.517","volume":"14","author":"MA Saubolle","year":"1978","unstructured":"Saubolle MA, Hoeprich PD. Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother. 1978;14(4):517\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"5241_CR34","first-page":"351","volume":"31","author":"I Yuliana, Sufiawati","year":"2025","unstructured":"Yuliana, Sufiawati I, Dewi IM, Hartantri Y. Evaluation of Antifungal Activity Against Candida albicans Isolates From HIV-Positive Patients with Oral Candidiasis in a Major Referral Hospital, West Java, Indonesia. HIV\/AIDS-Research and Palliative Care. Dec. 2025;31:351\u201360.","journal-title":"Dec"},{"issue":"12","key":"5241_CR35","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3390\/jof9121188","volume":"9","author":"I Franconi","year":"2023","unstructured":"Franconi I, Lupetti A. In vitro susceptibility tests in the context of antifungal resistance: Beyond minimum inhibitory concentration in Candida spp. J Fungi. 2023;9(12):1188.","journal-title":"J Fungi"},{"key":"5241_CR36","doi-asserted-by":"crossref","unstructured":"Desjardins P, Conklin D. NanoDrop microvolume quantitation of nucleic acids. J visualized experiments: JoVE. 2010;(45):2565.","DOI":"10.3791\/2565-v"},{"issue":"2","key":"5241_CR37","first-page":"179","volume":"53","author":"T Nas","year":"2008","unstructured":"Nas T, Kalkanci AY, Fidan I\u015e, Hizel K, Bolat S, Yolbakan S, Yilmaz E, Ozkan S, Kustimur S. Expression of ALS1, HWP1 and SAP4 genes in Candida albicans strains isolated from women with vaginitis. Folia Microbiol (Praha). 2008;53(2):179\u201383.","journal-title":"Folia Microbiol (Praha)"},{"key":"5241_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1099\/mic.0.26699-0","volume":"150","author":"CB Green","year":"2004","unstructured":"Green CB, Cheng G, Chandra J, Mukherjee P, Ghannoum MA, Hoyer LL. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology. 2004;150:267\u201375.","journal-title":"Microbiology"},{"key":"5241_CR39","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1038\/s41598-024-11597-x","volume":"14","author":"AM Dawoud","year":"2024","unstructured":"Dawoud AM, Saied SA, Torayah MM, Ramadan AE, Elaskary SA. Antifungal susceptibility and virulence determinants profile of Candida species isolated from patients with candidemia. Sci Rep. 2024;14:11597. https:\/\/doi.org\/10.1038\/s41598-024-11597-x.","journal-title":"Sci Rep"},{"issue":"4","key":"5241_CR40","doi-asserted-by":"publisher","first-page":"e00099","DOI":"10.1128\/cmr.00099-22","volume":"36","author":"AM Borman","year":"2023","unstructured":"Borman AM, Johnson EM. Changes in fungal taxonomy: mycological rationale and clinical implications. Clin Microbiol Rev. 2023;36(4):e00099\u201322.","journal-title":"Clin Microbiol Rev"},{"key":"5241_CR41","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1099\/jmm.0.46737-0","volume":"55","author":"JR Naglik","year":"2006","unstructured":"Naglik JR, Fostira F, Ruprai J, Staab JF, Challacombe SJ, Sundstrom P. Candida albicans HWP1 gene expression and host antibody responses in colonization and disease. J Med Microbiol. 2006;55:1323\u20137.","journal-title":"J Med Microbiol"},{"key":"5241_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejogrb.2008.12.020","volume":"144","author":"A Ahmad","year":"2009","unstructured":"Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol. 2009;144:68\u201371.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5241_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1556\/EUJMI-D-14-00027","volume":"4","author":"OA Olowe","year":"2014","unstructured":"Olowe OA, Makanjuola OB, Olowe R, Adekanle DA. Prevalence of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis among pregnant women receiving antenatal care in Southwestern Nigeria. Eur J Microbiol Immunol. 2014;4:193\u20137.","journal-title":"Eur J Microbiol Immunol"},{"key":"5241_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/sti.2003.004192","volume":"80","author":"E ERylander","year":"2004","unstructured":"Rylander E, Berglund A-L, Krassny C, Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with orogenital sex and frequent pain at intercourse. Sex Transm Infect. 2004;80:54\u20137","journal-title":"Sex Transm Infect"},{"issue":"9577","key":"5241_CR45","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","volume":"369","author":"JD Sobel","year":"2007","unstructured":"Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(07)60917-9. PMID 17560449. S2CID 33894309.","journal-title":"Lancet"},{"key":"5241_CR46","doi-asserted-by":"crossref","unstructured":"Xu J, Schwartz K, Bartoces M, Joseph M, Severson R, Sobel JD. Effect of antibiotics on vulvovaginal candidiasis: a Metro Net study. J Am Board Fam Med. 2008;21:261\u20138.","DOI":"10.3122\/jabfm.2008.04.070169"},{"key":"5241_CR47","doi-asserted-by":"crossref","unstructured":"Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A. The impact of oral contraception on vulvovaginal candidiasis. Contraception. 1995;51:293\u20137.","DOI":"10.1016\/0010-7824(95)00079-P"},{"key":"5241_CR48","doi-asserted-by":"crossref","unstructured":"Willems HM, Ahmed SS, Liu J, Xu Z, Peters BM. Vulvovaginal candidiasis: a current understanding and burning questions. J Fungi.\u00a02020;6(1):27.","DOI":"10.3390\/jof6010027"},{"key":"5241_CR49","unstructured":"Yadav K, Prakash S. Prevalence of vulvovaginal candidiasis in pregnancy. Glob J Med Med Sci. 2016;4:108\u201316."},{"key":"5241_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0002-9378(98)80001-X","volume":"178","author":"JD Sobe","year":"1998","unstructured":"Sobe JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obst Gynecol. 1998;178:203\u201311.","journal-title":"Am J Obst Gynecol"},{"issue":"2","key":"5241_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10647440400025629","volume":"13","author":"JP Ttrama","year":"2005","unstructured":"Ttrama JP, Adelson ME, Raphaelli I, Stemmer SM, Mmordechai E. Detection of Candida species in vaginal samples in a clinical laboratory setting. Infect Dis Obstet Gynecol. 2005;13(2):63\u20137.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"5241_CR52","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0002-9378(95)90347-X","volume":"173","author":"P Nyirjesy","year":"1995","unstructured":"Nyirjesy P, Seeney SM, Grody MHT, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol. 1995;173:820\u20133.","journal-title":"Am J Obstet Gynecol"},{"key":"5241_CR53","doi-asserted-by":"publisher","unstructured":"Sobel JD. Candidal vulvovaginitis. Clinical obstetrics and gynecology. 1993;36(1):153\u201365. https:\/\/doi.org\/10.1097\/00003081-199303000-00021.","DOI":"10.1097\/00003081-199303000-00021"},{"key":"5241_CR54","doi-asserted-by":"crossref","unstructured":"Bauters TGM, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol. 2002;187:569\u201374.","DOI":"10.1067\/mob.2002.125897"},{"issue":"8","key":"5241_CR55","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.5812\/jjm.12804","volume":"10","author":"S Hasanvand","year":"2017","unstructured":"Hasanvand S, Qomi HA, Kord M, Didehdar M. Molecular epidemiology and in vitro antifungal susceptibility of Candida isolates from women with vulvovaginal candidiasis in northern cities of Khuzestan Province. Iran Jundishapur J Microbiol. 2017;10(8):12804. https:\/\/doi.org\/10.5812\/jjm.12804.","journal-title":"Iran Jundishapur J Microbiol"},{"key":"5241_CR56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12905-018-0607-z","volume":"18","author":"A Bitew","year":"2018","unstructured":"Bitew A, Abebaw Y. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health. 2018;18:94. https:\/\/doi.org\/10.1186\/s12905-018-0607-z.","journal-title":"BMC Womens Health"},{"issue":"12","key":"5241_CR57","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","volume":"15","author":"H Koo","year":"2017","unstructured":"Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol. 2017;15(12):740\u201355.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"5241_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22270\/ujpr.v5i4.435","volume":"5","author":"AH Alhasani","year":"2020","unstructured":"Alhasani AH, Al-Akwa AAY, Al-Shamahy HA, Al-deen HS, Al-labani AM. Biofilm formation and antifungal susceptibility of Candida isolates from oral cavity after the introduction of fixed orthodontic appliances. Univers J Pharm Res. 2020;5(4):1\u20136. https:\/\/doi.org\/10.22270\/ujpr.v5i4.435.","journal-title":"Univers J Pharm Res"},{"issue":"1","key":"5241_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0974-777X.77288","volume":"3","author":"V Mohandas","year":"2011","unstructured":"Mohandas V, Ballal M. Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. J global Infect Dis. 2011;3(1):4\u20138.","journal-title":"J global Infect Dis"},{"key":"5241_CR60","doi-asserted-by":"crossref","unstructured":"Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infection and immunity. 2002;70(2):878\u201388.","DOI":"10.1128\/IAI.70.2.878-888.2002"},{"issue":"8","key":"5241_CR61","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.archoralbio.2007.01.009","volume":"52","author":"ZM Thein","year":"2007","unstructured":"Thein ZM, Samaranayake YH, Samaranayake LP. In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions. Arch Oral Biol. 2007;52(8):761\u20137.","journal-title":"Arch Oral Biol"},{"key":"5241_CR62","doi-asserted-by":"crossref","unstructured":"Malinovsk\u00e1 Z, \u010conkov\u00e1 E, V\u00e1czi P. Biofilm formation in medically important Candida species. J Fungi.\u00a02023;9(10):955.","DOI":"10.3390\/jof9100955"},{"key":"5241_CR63","unstructured":"Nandini P, Sujatha R. Phenotypic Evaluation Of Antifungal Susceptibility Pattern Of Candida albicans Isolated From Different Clinical Samples By Kirby-Bauer Disc Diffusion And Broth Microdilution Method To Fluconazole And Amphotericin B. J Pharm Negat Results. 2023;14(2)."},{"issue":"11","key":"5241_CR64","first-page":"DC01","volume":"9","author":"D KuMar","year":"2015","unstructured":"KuMar D, Bhattacharyya S, Gupta P, Banerjee G, Singh M. Comparative analysis of disc diffusion and E-test with broth micro-dilution for susceptibility testing of clinical Candida isolates against amphotericin B, fluconazole, voriconazole and caspofungin. J Clin Diagn research: JCDR. 2015;9(11):DC01.","journal-title":"J Clin Diagn research: JCDR"},{"issue":"1","key":"5241_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.18869\/acadpub.cmm.2.1.24","volume":"2","author":"P Badiee","year":"2016","unstructured":"Badiee P, Badali H, Diba K, Moghadam AG, Hosseininasab A, Jafarian H, Mohammadi R, Mirhendi H, Najafzadeh MJ, Shamsizadeh A, Soltani J. Susceptibility pattern of Candida albicans isolated from Iranian patients to antifungal agents. Curr Med Mycol. 2016;2(1):24.","journal-title":"Curr Med Mycol"},{"key":"5241_CR66","doi-asserted-by":"crossref","unstructured":"Mohammed MA, Mohammed AA, Khaled AA, Hassan AA, Mohammed M. In Vitro Antifungal Susceptibility of Candida albicans Isolated from Yemeni Patients with Denture Stomatitis. J Dentistry Oral Maxillofacial Surg. 2022;5(3).","DOI":"10.31579\/2643-6612\/034"},{"key":"5241_CR67","doi-asserted-by":"crossref","unstructured":"Gubran AN, Al-Baghdadi MA, Al-Haidary NM. Vulvovaginal candidiasis and antifungal susceptibility pattern of isolated Candida spp. among women in Aden Governorate, Yemen. BMC Infectious Diseases. 2026.","DOI":"10.1186\/s12879-025-12471-4"},{"key":"5241_CR68","doi-asserted-by":"crossref","unstructured":"Aslani N, Kokabi R, Moradi F, et al. Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles. Current Medical Mycology. 2021;7(4):27\u201334.","DOI":"10.18502\/cmm.7.4.8405"},{"key":"5241_CR69","doi-asserted-by":"crossref","unstructured":"Yenisehirli G, Bulut N, Yenisehirli A, Bulut Y. In vitro susceptibilities of Candida albicans isolates to antifungal agents in Tokat, Turkey. Jundishapur J Microbiol. 2015;8(9):e28057.","DOI":"10.5812\/jjm.28057"},{"key":"5241_CR70","first-page":"3193","volume":"2","author":"L Jayalakshmi","year":"2014","unstructured":"Jayalakshmi L, Ratnakumari G, Samson SH. Isolation, speciation and antifungal susceptibility testing of Candida from clinical specimens at a tertiary care hospital. School J Appl Med Sci. 2014;2:3193\u20138.","journal-title":"School J Appl Med Sci"},{"issue":"6","key":"5241_CR71","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1099\/0022-1317-51-6-479","volume":"51","author":"R Pelletier","year":"2002","unstructured":"Pelletier R, Loranger L, Marcotte H, De Carolis E. Voriconazole and fluconazole susceptibility of Candida isolates. J Med Microbiol. 2002;51(6):479\u201383.","journal-title":"J Med Microbiol"},{"issue":"1","key":"5241_CR72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5812\/jjm.4633","volume":"6","author":"A Zarei Mahmoudabadi","year":"2012","unstructured":"Zarei Mahmoudabadi A, Zarrin M, Beheshti Fard M. Antifungal susceptibility of Candida species isolated from candidura. Jundishapur J Microbiol. 2012;6(1):24\u20138.","journal-title":"Jundishapur J Microbiol"},{"key":"5241_CR73","doi-asserted-by":"crossref","unstructured":"Fleck R, Dietz A, Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother. 2007;59(4):767\u201371.","DOI":"10.1093\/jac\/dkl555"},{"key":"5241_CR74","first-page":"19","volume":"4","author":"T Shokohi","year":"2011","unstructured":"Shokohi T, Bandalizadeh Z, Hedayati MT, Mayahi S. In vitro antifungal susceptibility of Candida species isolated from orofaringeal lesions of patients with cancer to some antifungal agents. Jundishapur J Microbiol. 2011;4:19\u201326.","journal-title":"Jundishapur J Microbiol"},{"key":"5241_CR75","unstructured":"Bicmen C, Doluca M, Gulat S, Gunduz AT, Tuksavul F. Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus. New Microbiologica. 2012;35(3):327\u201334."},{"key":"5241_CR76","doi-asserted-by":"crossref","unstructured":"Khan MSA, Ahmad I, Aqil F, Owais M, Shahid M, Musarrat J. Virulence and pathogenicity of fungal pathogens with special reference to Candida albicans, Combating Fungal Infections. 2010:21\u2013\u200945.","DOI":"10.1007\/978-3-642-12173-9_2"},{"key":"5241_CR77","doi-asserted-by":"crossref","unstructured":"Ardehali SH, Azimi T, Fallah F et al. Molecular detection of ALS1, ALS3, HWP1 and SAP4 genes in Candida genus isolated from hospitalized patients in intensive care unit, Tehran, Iran, Cellular and Molecular Biology. 2019;65(4):15\u201322.","DOI":"10.14715\/cmb\/2019.65.4.3"},{"key":"5241_CR78","doi-asserted-by":"crossref","unstructured":"Shrief R, Zaki MES, el-Sehsah EM, Ghaleb S, Mofreh M. Study of antifungal susceptibility, virulence genes and bio film formation in Candida albicans. Open Microbiol J. 2019;13(1):241\u20138.","DOI":"10.2174\/1874285801913010241"},{"key":"5241_CR79","doi-asserted-by":"crossref","unstructured":"Inci M, Atalay MA, \u00d6zer B, et al. Investigations of ALS1 and HWP1 genes in clinical isolates of Candida albicans. Turkish J Med Sci. 2013;43(1):125\u201330.","DOI":"10.3906\/sag-1205-90"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05241-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05241-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05241-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:05:01Z","timestamp":1785441901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05241-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5241"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05241-y","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study complies with the ethical principles outlined in the Declaration of Helsinki concerning research involving human subjects. The proposal for this study was approved by the Research Medical Committee at the Faculty of Medicine and Health Sciences at Sana\u2019a University (July 10th, 2021: Ref.1012). Permission of the centers and hospitals was secured and written consent was taken from patients. Participants were assured of the confidentiality of their information and their right to withdraw from the study at any time without any consequences. Feedback regarding the results of the study was given to the participants at the end of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"681"}}